SC
SANA icon

Syon Capital’s Sana Biotechnology SANA Stock Holding History

Syon Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48K Hold
16,663
– – ﹤0.01% 903
2025
Q4 		$67.8K Hold
16,663
– – ﹤0.01% 892
2025
Q3 		$59.2K Hold
16,663
– – ﹤0.01% 810
2025
Q2 		$45.5K Sell
16,663
-6,203
-27% -$12.8K ﹤0.01% 725
2025
Q1 		$38.4K Buy
22,866
+6,203
+37% +$17.3K ﹤0.01% 580
2024
Q4 		$27.2K Buy
+16,663
New +$49.7K ﹤0.01% 561

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Syon Capital's SANA Position: Q1 2026 in Review

Syon Capital held its Sana Biotechnology (SANA) position steady in Q1 2026 at 16,663 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #903.

Syon Capital first reported a position in SANA in Q4 2024 and has held it in 6 quarters since. The position peaked at $67.8K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Syon Capital held 16,663 shares of Sana Biotechnology worth $48K as of Q1 2026.
  • Syon Capital left its Sana Biotechnology share count unchanged in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of Syon Capital's portfolio in Q1 2026, its #903 holding.
  • Syon Capital first reported a position in Sana Biotechnology in Q4 2024 and has held it in 6 quarters since.
  • Syon Capital's Sana Biotechnology position peaked at $67.8K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.